AI & Data
Significance 5/10
AI-Based Pathologic Response Assessment in Lung Cancer After Neoadjuvant Therapy
This study evaluates an AI system for assessing pathologic response in locally advanced non-small cell lung cancer following neoadjuvant chemo-immunotherapy. No abstract was available; significance is scored conservatively based on the clinically relevant topic.
The original study
Diagnostic accuracy of an AI-based pathologic response assessment in locally advanced non-small cell lung cancer after neoadjuvant chemo-immunotherapy.
- Authors
- Lee KC, Shin H, Ohn J, Park JH, Park S, Park IK, et al.
- Journal
- BMC cancer
- PMID
- 41857524